-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L3SMPjVDuMpQgOfFzGGp1DdU+EpBBpN8Bpwc0grn8kpMVVp78YX381hg5eGktGGc aRPGI2+PcVpTlmKRAHB2hw== 0000875320-09-000081.txt : 20090910 0000875320-09-000081.hdr.sgml : 20090910 20090910131707 ACCESSION NUMBER: 0000875320-09-000081 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090909 FILED AS OF DATE: 20090910 DATE AS OF CHANGE: 20090910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 091062264 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-09-09 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2009-09-09 4 M 0 6400 13.11 A 1072795 D Common Stock 2009-09-09 4 S 0 6400 37.00 D 1066395 D Common Stock 13286 I 401(k) Common Stock 207500 I Shares in trust Stock Options 13.11 2009-09-09 4 M 0 6400 0 D 2009-12-01 Common Stock 6400 70374 D Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $37.00 (range $36.68 to $37.28). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Shares held in trust for Dr. Boger's children. Dr. Boger disclaims beneficial ownership of such shares. Fully vested. Kenneth S. Boger, Attorney-In-Fact 2009-09-10 -----END PRIVACY-ENHANCED MESSAGE-----